About this item:

40 Views | 14 Downloads

Author Notes:

Stuart F. Quan, stuart_quan@hms.harvard.edu

Conceptualization, K.A.S., M.S., M.É.C., B.F. and R.I.L.; formal analysis, K.A.S., M.S., M.É.C., B.F., R.I.L. and S.F.Q.; data curation, M.É.C., R.L., P.G., E.T., A.A., R.I.L. and K.C.-S.; writing—original draft preparation, K.A.S., M.S., R.I.L. and S.F.Q.; writing—review and editing, M.É.C., K.C.-S., R.L., P.G., E.T., A.A., C.N.L., M.E.H., C.A.C., S.M.W.R., D.U.E., B.F., R.I.L., S.F.Q. and M.D.W. All authors have read and agreed to the published version of the manuscript.

The authors of this manuscript thank the entire staff of the Minnesota Department of Health and Los Angeles County Department of Health for their efforts in the COVID-19 response and help with the efforts required for this survey. We also thank all the people who participated in this survey for their contribution to our collective knowledge in the fight against COVID-19.

M. Czeisler reported personal fees from Vanda Pharmaceuticals Inc., research grants or gifts to Monash University from WHOOP, Inc., Hopelab, Inc., CDC Foundation, and the Centers for Disease Control and Prevention. C. Czeisler reported receiving grants and personal fees from Teva Pharma Australia, receiving grants from the National Institute of Occupational Safety and Health R01-OH-011773, personal fees from and equity interest in Vanda Pharmaceuticals Inc, educational and research support from Philips Respironics Inc, an endowed professorship provided to Harvard Medical School from Cephalon, Inc, an institutional gift from Alexandra Drane, and a patent on Actiwatch-2 and Actiwatch-Spectrum devices with royalties paid from Philips Respironics Inc. C. Czeisler’s interests were reviewed and managed by Brigham and Women’s Hospital and Partners HealthCare in accordance with their conflict of interest policies. C. Czeisler also served as a voluntary board member for the Institute for Experimental Psychiatry Research Foundation, Inc. Rajaratnam reported receiving grants and personal fees from Cooperative Research Centre for Alertness, Safety, and Productivity, receiving grants and institutional consultancy fees from Teva Pharma Australia and institutional consultancy fees from Vanda Pharmaceuticals, Circadian Therapeutics, BHP Billiton, and Herbert Smith Freehills. Quan has served as a consultant for Best Doctors, Bryte Foundation, Jazz Pharmaceuticals, and Whispersom. No other disclosures were reported.

Subject:

Research Funding:

This work was supported by the Centers for Disease Control and Prevention

M. Czeisler was supported by an Australian-American Fulbright Fellowship, with funding from The Kinghorn Foundation.

Keywords:

  • COVID-19

Intent among Parents to Vaccinate Children before Pediatric COVID-19 Vaccine Recommendations, Minnesota and Los Angeles County, California—May–September 2021

Show all authors Show less authors

Tools:

Journal Title:

Vaccines

Volume:

Volume 10, Number 9

Publisher:

Type of Work:

Article | Final Publisher PDF

Abstract:

Objectives: This study assessed the associations between parent intent to have their child receive the COVID-19 vaccination, and demographic factors and various child activities, including attendance at in-person education or childcare. Methods: Persons undergoing COVID-19 testing residing in Minnesota and Los Angeles County, California with children aged <12 years completed anonymous internet-based surveys between 10 May and 6 September 2021 to assess factors associated with intention to vaccinate their child. Factors influencing the parents’ decision to have their child attend in-person school or childcare were examined. Estimated adjusted odds rations (AORs, 95% CI) were computed between parents’ intentions regarding children’s COVID-19 vaccination and participation in school and extra-curricular activities using multinomial logistic regression. Results: Compared to parents intending to vaccinate their children (n = 4686 [77.2%]), those undecided (n = 874 [14.4%]) or without intention to vaccinate (n = 508 [8.4%]) tended to be younger, non-White, less educated, and themselves not vaccinated against COVID-19. Their children more commonly participated in sports (aOR:1.51 1.17–1.95) and in-person faith or community activities (aOR:4.71 3.62–6.11). A greater proportion of parents without intention to vaccinate (52.5%) indicated that they required no more information to make their decision in comparison to undecided parents (13.2%). They further indicated that additional information regarding vaccine safety and effectiveness would influence their decision. COVID-19 mitigation measures were the most common factors influencing parents’ decision to have their child attend in-person class or childcare. Conclusions: Several demographic and socioeconomic factors are associated with parents’ decision whether to vaccinate their <12-year-old children for COVID-19. Child participation in in-person activities was associated with parents’ intentions not to vaccinate. Tailored communications may be useful to inform parents’ decisions regarding the safety and effectiveness of vaccination.

Copyright information:

© 2022 by the authors.

This is an Open Access work distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/).
Export to EndNote